Paper

Gabapentin in neuropathic pain syndromes: a randomised, double-blind, placebo-controlled trial

Published Oct 1, 2002 · M. Serpell

Pain

421

Citations

Influential Citations

Abstract

Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.

RCT

Large Human Trial

Highly Cited

Study Snapshot

Gabapentin effectively reduces pain and improves quality-of-life measures in patients with various neuropathic pain syndromes.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Gabapentin in neuropathic pain syndromes: a randomised, double-blind, placebo-controlled trial

References

Citations